Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.45B | 55.48B | 51.06B | 81.53B | 61.79B | 39.74B |
Gross Profit | 56.45B | 6.92B | 3.87B | 31.32B | 19.81B | 4.04B |
EBITDA | 2.14B | 13.39B | 11.37B | 36.96B | 24.48B | 8.68B |
Net Income | 7.09B | 6.11B | 3.82B | 29.20B | 17.94B | 2.85B |
Balance Sheet | ||||||
Total Assets | 86.97B | 87.70B | 82.58B | 93.68B | 72.27B | 56.12B |
Cash, Cash Equivalents and Short-Term Investments | 8.91B | 8.15B | 6.70B | 11.00B | 11.84B | 5.87B |
Total Debt | 17.04B | 16.48B | 14.81B | 15.64B | 15.34B | 15.37B |
Total Liabilities | 30.51B | 29.75B | 27.49B | 28.65B | 26.68B | 25.26B |
Stockholders Equity | 55.41B | 56.92B | 54.03B | 63.99B | 44.51B | 29.85B |
Cash Flow | ||||||
Free Cash Flow | 8.19B | 7.21B | 6.00B | 30.31B | 19.05B | 6.51B |
Operating Cash Flow | 13.08B | 11.41B | 9.64B | 34.48B | 22.02B | 7.83B |
Investing Cash Flow | -7.82B | -7.92B | 4.08B | -21.62B | -8.34B | -1.02B |
Financing Cash Flow | -5.65B | -3.50B | -16.80B | -14.13B | -7.90B | -5.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
87 Outperform | $33.97B | 4.91 | 12.75% | 10.33% | 16.28% | 567.66% | |
80 Outperform | $1.73B | 3.90 | 13.38% | 3.54% | 5.63% | -17.54% | |
76 Outperform | $2.21B | 17.82 | 5.11% | 7.78% | 2.95% | -61.74% | |
75 Outperform | $1.87B | 0.79 | 72.40% | 47.67% | 65.83% | ― | |
72 Outperform | $3.29B | 7.01 | 19.70% | 1.33% | 8.75% | 56.21% | |
68 Neutral | $1.65B | 14.52 | 6.06% | 9.70% | -7.73% | -39.13% | |
66 Neutral | £2.67B | 12.77 | 3.50% | 3.23% | 2.47% | -24.22% |